NPPB and systemic sclerosis: Considering the growing interest in the identification of specific markers to assess the diagnosis and prognosis of CRS, we demonstrated altered levels of NT-proBNP, suPAR, galectin-3, sNGAL, and uNGAL in SSc patients compared with HC.